טוען...
Druggable Molecular Targets for the Treatment of Triple Negative Breast Cancer
Breast cancer (BC) is still the most common cancer among women worldwide. Amongst the subtypes of BC, triple negative breast cancer (TNBC) is characterized by deficient expression of estrogen, progesterone, and human epidermal growth factor receptor 2 receptors. These patients are therefore not give...
שמור ב:
| הוצא לאור ב: | J Breast Cancer |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Korean Breast Cancer Society
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6769384/ https://ncbi.nlm.nih.gov/pubmed/31598336 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4048/jbc.2019.22.e39 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|